Advanced Therapies – Opportunities and Challenges – Speakers

Advanced Therapies – Opportunities and Challenges

14th November, London

Request Invitation

Speakers

Karen Aiach

Chief Executive Officer,
Lysogene

Biography

Richard Barker

Founding Director,
Centre for the Advancement of Sustainable Medical Innovation (CASMI)

Biography

Steve Bates

Chief Executive Officer,
BioIndustry Association (BIA)

Biography

Eduardo Bravo

Chief Executive Officer,
TiGenix
& EBE President

Biography

Ian Campbell

Director for Health and Life Sciences,
Innovate UK

Biography

Barbara Freischem

Executive Director,
European Biopharmaceutical Enterprises (EBE)

Biography

Peter Goodfellow

Scientific Advisor,
Abingworth

Biography

Karen Hodgkin

Chief Operating Officer,
Cell Medica

Biography

Seigo Izumo

Senior Vice President for Regenerative Medicine,
Takeda Pharmaceuticals

Biography

Adrien Lemoine

VP Business Development & Operations,
Orchard Therapeutics

Biography

James McBlane

CAT Member,
Preclinical Assessor,
UK Medicines and Healthcare Products Regulatory Agency (MHRA)

Biography

Deborah Morrison

Senior Scientific Adviser,
National Institute for Health and Care Excellence (NICE)

Biography

Lord James O’Shaughnessy

Parliamentary Under Secretary of State for Health (Lords),
UK Government

Biography

Magda Papadaki

Head of Manufacturing Innovation,
Association of the British Pharmaceutical Industry (ABPI)

Biography

Gabriele Proetzel,

Director, Regenerative Medicine,
Takeda

Biography

Qasim Rafiq

Senior Lecturer,
Bioprocessing of Regenerative, Cellular and Gene Therapies,
UCL

Biography

Christian K Schneider

Director,
National Institute for Biological Standards and Control
(NIBSC)

Biography

Duane Schulthess

Managing Director,
Vital Transformation

Biography

Michael Stein

Chief Executive Officer and Chairman,
Oxstem

Biography

Keith Thompson

Chief Executive Officer,
Cell and Gene Therapy Catapult

Biography

Supported by:

2017-10-12T07:22:56+00:00